Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.

Lees C, Godin J, McElhaney JE, McNeil SA, Loeb M, Hatchette TF, LeBlanc J, Bowie W, Boivin G, McGeer A, Poirier A, Powis J, Semret M, Webster D, Andrew MK.

J Infect Dis. 2020 Mar 9. pii: jiaa092. doi: 10.1093/infdis/jiaa092. [Epub ahead of print] No abstract available.

PMID:
32147711
2.

Influenza surveillance case definitions miss a substantial proportion of older adults hospitalized with laboratory-confirmed influenza: A report from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network.

Andrew MK, McElhaney JE, McGeer AA, Hatchette TF, Leblanc J, Webster D, Bowie W, Poirier A, Nichols MK, McNeil SA; Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance Network Investigators.

Infect Control Hosp Epidemiol. 2020 Mar 9:1-6. doi: 10.1017/ice.2020.22. [Epub ahead of print]

PMID:
32146920
3.

Corrigendum to "Estimates of the current and future burden of cancer attributable to lack of physical activity in Canada" [Prev. Med. 122 (2019) 65-72].

Friedenreich CM, Barberio AM, Pader J, Poirier AE, Ruan Y, Grevers X, Walter SD, Villeneuve PJ, Brenner DR; ComPARe Study Team.

Prev Med. 2020 Mar 3:106045. doi: 10.1016/j.ypmed.2020.106045. [Epub ahead of print] No abstract available.

PMID:
32143862
4.

Decisional needs assessment of patients with complex care needs in primary care.

Poitras ME, Hudon C, Godbout I, Bujold M, Pluye P, Vaillancourt VT, Débarges B, Poirier A, Prévost K, Spence C, Légaré F.

J Eval Clin Pract. 2019 Dec 9. doi: 10.1111/jep.13325. [Epub ahead of print]

PMID:
31815348
5.

Age-standardized cancer-incidence trends in Canada, 1971-2015.

Brenner DR, Ruan Y, Shaw E, O'Sullivan D, Poirier AE, Heer E, Villeneuve PJ, Walter SD, Friedenreich CM, Smith L, De P.

CMAJ. 2019 Nov 18;191(46):E1262-E1273. doi: 10.1503/cmaj.190355.

6.

AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice.

Doyle BM, Turner SMF, Sunshine MD, Doerfler PA, Poirier AE, Vaught LA, Jorgensen ML, Falk DJ, Byrne BJ, Fuller DD.

Mol Ther Methods Clin Dev. 2019 Aug 31;15:194-203. doi: 10.1016/j.omtm.2019.08.009. eCollection 2019 Dec 13.

7.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.

Picard C, Poirier A, Bélanger S, Labonté A, Auld D, Poirier J; PREVENT-AD Research Group.

PLoS One. 2019 Aug 22;14(8):e0220254. doi: 10.1371/journal.pone.0220254. eCollection 2019.

8.

Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.

Jarras H, Bourque M, Poirier AA, Morissette M, Coulombe K, Di Paolo T, Soulet D.

J Neuroendocrinol. 2020 Jan;32(1):e12782. doi: 10.1111/jne.12782. Epub 2019 Sep 10.

PMID:
31430407
9.

Resistance of the oyster pathogen Vibrio tasmaniensis LGP32 against grazing by Vannella sp. marine amoeba involves Vsm and CopA virulence factors.

Robino E, Poirier AC, Amraoui H, Le Bissonnais S, Perret A, Lopez-Joven C, Auguet JC, Rubio TP, Cazevieille C, Rolland JL, Héchard Y, Destoumieux-Garzón D, Charrière GM.

Environ Microbiol. 2019 Aug 6. doi: 10.1111/1462-2920.14770. [Epub ahead of print]

PMID:
31386262
10.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2020 Feb;69(2):256-264. doi: 10.1099/jmm.0.001032. Epub 2019 Jun 28.

PMID:
31264957
11.

Corrigendum to "The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results" [Prev. Med. 122 (2019) 140-147].

Poirier AE, Ruan Y, Volesky KD, King WD, O'Sullivan DE, Gogna P, Walter SD, Villeneuve PJ, Friedenreich CM, Brenner DR; ComPARe Study Team.

Prev Med. 2019 Dec;129:105732. doi: 10.1016/j.ypmed.2019.05.020. Epub 2019 May 25. No abstract available.

PMID:
31138440
12.

Corrigendum to "Estimates of the current and future burden of cancer attributable to alcohol consumption in Canada" [Prev. Med. 122 (2019) 40-48].

Grevers X, Ruan Y, Poirier AE, Walter SD, Villeneuve PJ, Friedenreich CM, Brenner DR; ComPARe Study Team.

Prev Med. 2019 Dec;129:105726. doi: 10.1016/j.ypmed.2019.05.014. Epub 2019 May 25. No abstract available.

PMID:
31133293
13.

Corrigendum to "Estimates of the current and future burden of cancer attributable to lack of physical activity in Canada" [Prev. Med. 122 (2019) 65-72].

Friedenreich CM, Barberio AM, Pader J, Poirier AE, Ruan Y, Grevers X, Walter SD, Villeneuve PJ, Brenner DR; ComPARe Study Team.

Prev Med. 2019 Aug;125:78. doi: 10.1016/j.ypmed.2019.05.015. Epub 2019 May 25. No abstract available.

PMID:
31133292
14.

Corrigendum to "Estimates of the current and future burden of cancer attributable to low fruit and vegetable consumption in Canada" [Prev. Med. 122 (2019) 20-30].

Poirier AE, Ruan Y, Hebert LA, Greversa X, Walter SD, Villeneuve PJ, Brenner DR, Friedenreich CM; ComPARe Study Team.

Prev Med. 2019 Aug;125:79. doi: 10.1016/j.ypmed.2019.05.013. Epub 2019 May 25. No abstract available.

PMID:
31133290
15.

Estimates of the current and future burden of cancer attributable to active and passive tobacco smoking in Canada.

Poirier AE, Ruan Y, Grevers X, Walter SD, Villeneuve PJ, Friedenreich CM, Brenner DR; ComPARe Study Team.

Prev Med. 2019 May;122:9-19. doi: 10.1016/j.ypmed.2019.03.015.

PMID:
31078177
16.

Estimates of the current and future burden of cancer attributable to sedentary behavior in Canada.

Friedenreich CM, Pader J, Barberio AM, Ruan Y, Poirier AE, Grevers X, Walter SD, Villeneuve PJ, Brenner DR; ComPARe Study Team.

Prev Med. 2019 May;122:73-80. doi: 10.1016/j.ypmed.2019.03.009.

PMID:
31078175
17.

Estimates of the current and future burden of cancer attributable to lack of physical activity in Canada.

Friedenreich CM, Barberio AM, Pader J, Poirier AE, Ruan Y, Grevers X, Walter SD, Villeneuve PJ, Brenner DR; ComPARe Study Team.

Prev Med. 2019 May;122:65-72. doi: 10.1016/j.ypmed.2019.03.008. Erratum in: Prev Med. 2019 Aug;125:78. Erratum in: Prev Med. 2020 Mar 3;:106045.

PMID:
31078174
18.

Estimates of the current and future burden of cancer attributable to excess body weight and abdominal adiposity in Canada.

Brenner DR, Poirier AE, Ruan Y, Hebert LA, Grevers X, Walter SD, Villeneuve PJ, Friedenreich CM; ComPARe Study Team.

Prev Med. 2019 May;122:49-64. doi: 10.1016/j.ypmed.2019.03.014.

PMID:
31078173
19.

Estimates of the current and future burden of cancer attributable to alcohol consumption in Canada.

Grevers X, Ruan Y, Poirier AE, Walter SD, Villeneuve PJ, Friedenreich CM, Brenner DR; ComPARe Study Team.

Prev Med. 2019 May;122:40-48. doi: 10.1016/j.ypmed.2019.03.020. Erratum in: Prev Med. 2019 Dec;129:105726.

PMID:
31078172
20.

Estimates of the current and future burden of cancer attributable to red and processed meat consumption in Canada.

Ruan Y, Poirier AE, Hebert LA, Grevers X, Walter SD, Villeneuve PJ, Brenner DR, Friedenreich CM; ComPARe Study Team.

Prev Med. 2019 May;122:31-39. doi: 10.1016/j.ypmed.2019.03.011.

PMID:
31078171
21.

The burden of cancer attributable to modifiable risk factors in Canada: Methods overview.

Brenner DR, Friedenreich CM, Ruan Y, Poirier AE, Walter SD, King WD, Franco EL, Demers PA, Villeneuve PJ, Grevers X, Nuttall R, Smith LM, Volesky KD, O'Sullivan DE, De P; ComPARe Study Team.

Prev Med. 2019 May;122:3-8. doi: 10.1016/j.ypmed.2019.03.007.

PMID:
31078170
22.

Estimates of the current and future burden of cancer attributable to low fruit and vegetable consumption in Canada.

Poirier AE, Ruan Y, Hebert LA, Grevers X, Walter SD, Villeneuve PJ, Brenner DR, Friedenreich CM; ComPARe Study Team.

Prev Med. 2019 May;122:20-30. doi: 10.1016/j.ypmed.2019.03.013. Erratum in: Prev Med. 2019 Aug;125:79.

PMID:
31078169
23.

The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results.

Poirier AE, Ruan Y, Volesky KD, King WD, O'Sullivan DE, Gogna P, Walter SD, Villeneuve PJ, Friedenreich CM, Brenner DR; ComPARe Study Team.

Prev Med. 2019 May;122:140-147. doi: 10.1016/j.ypmed.2019.04.007. Erratum in: Prev Med. 2019 Dec;129:105732.

PMID:
31078167
24.

The future burden of cancer in Canada: Long-term cancer incidence projections 2013-2042.

Poirier AE, Ruan Y, Walter SD, Franco EL, Villeneuve PJ, King WD, Volesky KD, O'Sullivan DE, Friedenreich CM, Brenner DR; ComPARe Study Team.

Cancer Epidemiol. 2019 Apr;59:199-207. doi: 10.1016/j.canep.2019.02.011. Epub 2019 Mar 1.

25.

Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs.

Poirier A, Weetall M, Heinig K, Bucheli F, Schoenlein K, Alsenz J, Bassett S, Ullah M, Senn C, Ratni H, Naryshkin N, Paushkin S, Mueller L.

Pharmacol Res Perspect. 2018 Nov 29;6(6):e00447. doi: 10.1002/prp2.447. eCollection 2018 Dec.

26.

Habitat use strategy influences the tissue signature of trace elements including rare earth elements in an urban-adapted omnivorous bird.

Brown L, Rosabal M, Sorais M, Poirier A, Widory D, Verreault J.

Environ Res. 2019 Jan;168:261-269. doi: 10.1016/j.envres.2018.10.004. Epub 2018 Oct 11.

PMID:
30342322
27.

Improving 3D-printing of megavoltage X-rays radiotherapy bolus with surface-scanner.

Dipasquale G, Poirier A, Sprunger Y, Uiterwijk JWE, Miralbell R.

Radiat Oncol. 2018 Oct 19;13(1):203. doi: 10.1186/s13014-018-1148-1.

28.

A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.

Sturm S, Günther A, Jaber B, Jordan P, Al Kotbi N, Parkar N, Cleary Y, Frances N, Bergauer T, Heinig K, Kletzl H, Marquet A, Ratni H, Poirier A, Müller L, Czech C, Khwaja O.

Br J Clin Pharmacol. 2019 Jan;85(1):181-193. doi: 10.1111/bcp.13786. Epub 2018 Nov 16.

29.

How to engage patients in research and quality improvement in community-based primary care settings: protocol for a participatory action research pilot study.

Haesebaert J, Samson I, Lee-Gosselin H, Guay-Bélanger S, Proteau JF, Drouin G, Guimont C, Vigneault L, Poirier A, Sanon PN, Roch G, Poitras MÈ, LeBlanc A, Légaré F.

Res Involv Engagem. 2018 Oct 1;4:30. doi: 10.1186/s40900-018-0113-3. eCollection 2018.

30.

Estimating the current and future cancer burden in Canada: methodological framework of the Canadian population attributable risk of cancer (ComPARe) study.

Brenner DR, Poirier AE, Walter SD, King WD, Franco EL, Demers PA, Villeneuve PJ, Ruan Y, Khandwala F, Grevers X, Nuttall R, Smith L, De P, Volesky K, O'Sullivan D, Hystad P, Friedenreich CM; ComPARe Study Group.

BMJ Open. 2018 Aug 1;8(7):e022378. doi: 10.1136/bmjopen-2018-022378.

31.

Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA).

Ratni H, Ebeling M, Baird J, Bendels S, Bylund J, Chen KS, Denk N, Feng Z, Green L, Guerard M, Jablonski P, Jacobsen B, Khwaja O, Kletzl H, Ko CP, Kustermann S, Marquet A, Metzger F, Mueller B, Naryshkin NA, Paushkin SV, Pinard E, Poirier A, Reutlinger M, Weetall M, Zeller A, Zhao X, Mueller L.

J Med Chem. 2018 Aug 9;61(15):6501-6517. doi: 10.1021/acs.jmedchem.8b00741. Epub 2018 Jul 25.

PMID:
30044619
32.

Multistep building of a soft plant protein film at the air-water interface.

Poirier A, Banc A, Stocco A, In M, Ramos L.

J Colloid Interface Sci. 2018 Sep 15;526:337-346. doi: 10.1016/j.jcis.2018.04.087. Epub 2018 Apr 26.

PMID:
29751267
33.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
34.

Caring for seniors living with dementia means caring for their caregivers too.

Poirier A, Voyer P, Légaré F, Morin M, Witteman HO, Kröger E, Martineau B, Rodríguez C, Giguere AM.

Can J Public Health. 2018 Jan 22;108(5-6):e639-e642. doi: 10.17269/cjph.108.6217.

35.

Alcohol consumption and low-risk drinking guidelines among adults: a cross-sectional analysis from Alberta's Tomorrow Project.

Brenner DR, Haig TR, Poirier AE, Akawung A, Friedenreich CM, Robson PJ.

Health Promot Chronic Dis Prev Can. 2017 Dec;37(12):413-424. doi: 10.24095/hpcdp.37.12.03. English, French.

36.

Measures of excess body weight and anthropometry among adult Albertans: cross-sectional results from Alberta's tomorrow project cohort.

Brenner DR, Poirier AE, Haig TR, Akawung A, Friedenreich CM, Robson PJ.

BMC Public Health. 2017 Nov 25;17(1):899. doi: 10.1186/s12889-017-4887-2.

37.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network.

Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators; Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators.

Influenza Other Respir Viruses. 2018 Mar;12(2):232-240. doi: 10.1111/irv.12521. Epub 2018 Jan 24.

38.

Cancer incidence attributable to lifestyle and environmental factors in Alberta in 2012: summary of results.

Grundy A, Poirier AE, Khandwala F, Grevers X, Friedenreich CM, Brenner DR.

CMAJ Open. 2017 Jul 7;5(3):E540-E545. doi: 10.9778/cmajo.20160045.

39.

Lung cancer incidence attributable to residential radon exposure in Alberta in 2012.

Grundy A, Brand K, Khandwala F, Poirier A, Tamminen S, Friedenreich CM, Brenner DR.

CMAJ Open. 2017 Jun 28;5(2):E529-E534. doi: 10.9778/cmajo.20160053.

40.

Cancer incidence attributable to air pollution in Alberta in 2012.

Poirier AE, Grundy A, Khandwala F, Friedenreich CM, Brenner DR.

CMAJ Open. 2017 Jun 28;5(2):E524-E528. doi: 10.9778/cmajo.20160040.

41.

Cancer incidence attributable to inadequate physical activity in Alberta in 2012.

Brenner DR, Poirier AE, Grundy A, Khandwala F, McFadden A, Friedenreich CM.

CMAJ Open. 2017 May 3;5(2):E338-E344. doi: 10.9778/cmajo.20160044.

42.

Cancer incidence attributable to excess body weight in Alberta in 2012.

Brenner DR, Poirier AE, Grundy A, Khandwala F, McFadden A, Friedenreich CM.

CMAJ Open. 2017 Apr 28;5(2):E330-E336. doi: 10.9778/cmajo.20160039.

43.

Cancer incidence attributable to alcohol consumption in Alberta in 2012.

Grundy A, Poirier AE, Khandwala F, McFadden A, Friedenreich CM, Brenner DR.

CMAJ Open. 2016 Sep 21;4(3):E507-E514. doi: 10.9778/cmajo.20160070. eCollection 2016 Jul-Sep.

44.

Cancer incidence attributable to insufficient fibre consumption in Alberta in 2012.

Grundy A, Poirier AE, Khandwala F, McFadden A, Friedenreich CM, Brenner DR.

CMAJ Open. 2017 Jan 4;5(1):E7-E13. doi: 10.9778/cmajo.20160043. eCollection 2017 Jan-Mar.

45.

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

Boisdron-Celle M, Metges JP, Capitain O, Adenis A, Raoul JL, Lecomte T, Lam YH, Faroux R, Masliah C, Poirier AL, Berger V, Morel A, Gamelin E.

Semin Oncol. 2017 Feb;44(1):24-33. doi: 10.1053/j.seminoncol.2017.02.007. Epub 2017 Feb 9.

PMID:
28395759
46.

[Urinary catheters prevalence study in a university hospital].

Carrouget J, Legeay C, Poirier A, Azzouzi AR, Zahar JR, Bigot P.

Prog Urol. 2017 Apr;27(5):305-311. doi: 10.1016/j.purol.2017.03.006. Epub 2017 Apr 7. French.

PMID:
28392431
47.

Comparison of cobas 4800, m2000, Viper XTR, and Infinity 80 Automated Instruments When Processing Urine Specimens for the Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae.

Chernesky MA, Jang D, Gilchrist J, Smieja M, Arias M, Hatchette T, Poirier A, Mayne D, Ratnam S.

Sex Transm Dis. 2017 Mar;44(3):161-165. doi: 10.1097/OLQ.0000000000000570.

PMID:
28182591
48.

Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.

Poirier AA, Aubé B, Côté M, Morin N, Di Paolo T, Soulet D.

Parkinsons Dis. 2016;2016:6762528. doi: 10.1155/2016/6762528. Epub 2016 Dec 6. Review.

49.

Cancer incidence attributable to red and processed meat consumption in Alberta in 2012.

Grundy A, Poirier AE, Khandwala F, McFadden A, Friedenreich CM, Brenner DR.

CMAJ Open. 2016 Dec 13;4(4):E768-E775. doi: 10.9778/cmajo.20160036. eCollection 2016 Oct-Dec.

50.

Cancer incidence attributable to insufficient fruit and vegetable consumption in Alberta in 2012.

Grundy A, Poirier AE, Khandwala F, McFadden A, Friedenreich CM, Brenner DR.

CMAJ Open. 2016 Dec 12;4(4):E760-E767. doi: 10.9778/cmajo.20160037. eCollection 2016 Oct-Dec.

Supplemental Content

Loading ...
Support Center